Court Rules
All enforcement actions
SettlementHigh RiskMultistate

Minnesota AG reaches settlement with generic-drug manufacturer Glenmark for price-fixing conspiracy

Glenmark PharmaceuticalsJuly 17, 2026Minnesota Attorney General

Penalty Amount

$29,600,000

Summary

Minnesota Attorney General Keith Ellison joined a 48-state coalition in a $29.6 million settlement with generic-drug manufacturer Glenmark to resolve allegations of a widespread conspiracy to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate lawsuits and implement internal reforms to ensure compliance with antitrust laws.

Remedy

Glenmark will pay $29.6 million nationally, including $187,000 to Minnesota, cooperate in ongoing multistate lawsuits against 33 corporate defendants and 25 individual executives, and implement internal reforms to ensure fair competition and compliance with antitrust laws.

Monetary PenaltyCompliance ProgramReporting Requirements

Contract Impact

In-house legal teams should review vendor agreements with generic drug manufacturers for any clauses that could facilitate price fixing or market allocation, such as pricing coordination, information sharing, or non-compete provisions. Customer agreements should be examined for pricing terms and any provisions that might restrict competition. Employee contracts and confidentiality agreements should be updated to prohibit discussions with competitors about pricing, market share, or customer allocation. Additionally, compliance programs should include antitrust training and reporting mechanisms for potential collusion.

Contract Search Terms

price fixingantitrust compliancegeneric drug pricingmarket allocationcollusionfair competitioninternal reformscooperation agreementrestitutiongeneric prescription drugs

Laws Cited

Sherman ActMinnesota Antitrust Law
15 U.S.C. § 1

Violation Types

Entity Details

Entity

Glenmark Pharmaceuticals

Industry

Pharmaceuticals

Multistate Coalition

Connecticut Attorney General William TongAlaskaArizonaCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaIdahoIllinoisIndianaIowaKansasKentuckyMaineMarylandMassachusettsMichiganMississippiMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaNorthern Mariana IslandsOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeUtahU.S. Virgin IslandsVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

Official Sources

Source Evidence

Entity Name
"Glenmark"
Fine Amount
"$29.6 million nationwide settlement with Glenmark"
Fine Amount
"Minnesota’s share of today’s settlement with Glenmark that Attorney General Ellison recovered is more than $187,000"
Violation Types
"engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade"
Laws Cited
"antitrust laws"
Remedy Types
"Glenmark will cooperate in three ongoing multistate lawsuits"

Related Enforcement Actions

OR

Glenmark Pharmaceuticals

$29.6M

Oregon Attorney General Dan Rayfield and a bipartisan coalition of states reached a $29.6 million settlement with Glenmark, a generic drug manufacturer accused of conspiring with other pharmaceutical companies to inflate prices and limit competition for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate litigations and implement internal reforms to ensure fair competition and antitrust compliance.

CO

Glenmark Pharmaceuticals

$29.6M

Attorney General Phil Weiser joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals. The settlement resolves allegations that Glenmark participated in a widespread conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Glenmark also agreed to cooperate in ongoing multistate litigation and implement internal reforms.

MN

L’Oréal and its subsidiaries

Minnesota Attorney General Keith Ellison filed a consumer-protection lawsuit alleging that L’Oréal and its subsidiaries marketed chemical hair relaxers as safe while concealing cancer risks, particularly from Black women and girls. The state seeks civil penalties, consumer restitution, and an injunction requiring adequate health-risk warnings; these are requested remedies, not an outcome reported in the release.

MN

Minnesota Attorney General's Office

Minnesota Attorney General Keith Ellison joined a coalition of 22 attorneys general in filing an amicus brief opposing the federal government’s lawsuit concerning California’s voter rolls. The press release describes election litigation and does not announce a privacy enforcement action, penalty, or remedy.

MN

Office of Minnesota Attorney General Keith Ellison

Minnesota Attorney General Keith Ellison released an election incident reporting form and updated guidance concerning intimidation, deceptive election information, and deepfakes. The release invites reports and says the Office may investigate matters that may violate Minnesota law; it does not announce a settlement, penalty, or other enforcement remedy.

MN

Trajector Holdings, LLC

Minnesota Attorney General Keith Ellison issued a consumer alert explaining how veterans, their families, and others who believe Trajector Holdings owes them money can file claims in the company’s Chapter 11 bankruptcy. The release announces no privacy violation, enforcement penalty, or remedy against the company.